Incidence and risk factors of cutaneous reactions to the first COVID-19 booster vaccine

Allergy. 2024 Jul 9. doi: 10.1111/all.16223. Online ahead of print.

Liam R Smith¹, Ruchi J Shah¹, Andrew J King^{1

2}, Erica S Shenoy^{2

3

4}, Adam B Landman^{2

5}, Dean M Hashimoto^{2

6}, Kimberly Blumenthal^{1

2}

¹ Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Harvard Medical School, Boston, Massachusetts, USA.
³ Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁴ Infection Control Unit, Mass General Brigham, Boston, Massachusetts, USA.
⁵ Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
⁶ Occupational Health Services, Mass General Brigham, Boston, Massachusetts, USA.

No abstract available

Keywords: allergy; angioedema; hives; hypersensitivity; mRNA; rash; skin; vaccine.

Publication types